Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELUTIA INC.ELUT · Entity 7342 | Director · 10% owner | June 11, 2026 | June 15, 2026 |
| ORAMED PHARMACEUTICALS INC.ORMP · Entity 6311 | Director | March 21, 2022 | March 23, 2022 |
| Ocugen, Inc.HSGX · Entity 5550 | Director | February 08, 2019 | February 11, 2019 |
| Quantum-Si IncQSI · Entity 6440 | Director | May 18, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELUTIA INC.
Report date June 11, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.96 · Expires 2036-06-11 | Direct | 159,590 |
Reported balance
After 2026-06-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 159,590 · Balance 159,590 F1: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date.
ORAMED PHARMACEUTICALS INC.
Report date March 21, 2022 · Filed March 23, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,661 |
Reported balance
After 2022-03-21 transaction · row 1
1 source rowRow 1 · 2022-03-21 · Sale · Disposed 10,000 · Balance 46,661 |
Ocugen, Inc.
Report date February 08, 2019 · Filed February 11, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 418,639 |
Reported balance
After 2019-02-08 transaction · row 1
1 source rowRow 1 · 2019-02-08 · Exercise / conversion · Acquired 173,076 · Balance 418,639 F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 66,666 |
Reported balance
After 2019-02-08 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2019-02-08 · Exercise / conversion · Acquired 33,333 · Balance 66,666 F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019. F2: The reportable securities are owned by the Alison N Hoffman and Kevin L Rakin Irrevocable Trust For Sarah Hoffman Rakin. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 66,666 |
Reported balance
After 2019-02-08 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2019-02-08 · Exercise / conversion · Acquired 33,333 · Balance 66,666 F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019. F3: The reportable securities are owned by the Alison N Hoffman and Kevin L Rakin Irrevocable Trust For Julia Hoffman Rakin. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 257,846 |
Reported balance
After 2019-02-08 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2019-02-08 · Exercise / conversion · Acquired 111,111 · Balance 257,846 F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019. F4: The reportable securities are owned by the Kevin L Rakin Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose, except to the extent of his pecuniary interest therein. |
| Common Stock Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2023-10-10 | Direct | 0 |
Reported balance
After 2019-02-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-02-08 · Exercise / conversion · Disposed 173,076 · Balance 0 F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019. |
| Common Stock Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2021-11-22 | IndirectSee Footnote | 0 |
Reported balance
After 2019-02-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-02-08 · Exercise / conversion · Disposed 33,333 · Balance 0 F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019. F2: The reportable securities are owned by the Alison N Hoffman and Kevin L Rakin Irrevocable Trust For Sarah Hoffman Rakin. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose, except to the extent of his pecuniary interest therein. |
| Common Stock Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2021-11-22 | IndirectSee Footnote | 0 |
Reported balance
After 2019-02-08 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-02-08 · Exercise / conversion · Disposed 33,333 · Balance 0 F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019. F3: The reportable securities are owned by the Alison N Hoffman and Kevin L Rakin Irrevocable Trust For Julia Hoffman Rakin. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose, except to the extent of his pecuniary interest therein. |
| Common Stock Warrant (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.01 · Expires 2021-11-22 | IndirectSee Footnote | 0 |
Reported balance
After 2019-02-08 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-02-08 · Exercise / conversion · Disposed 111,111 · Balance 0 F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019. F4: The reportable securities are owned by the Kevin L Rakin Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose, except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The per share exercise price of each Common Stock Warrant was re-priced to $0.01 pursuant to a warrant exercise agreement entered into with the Issuer on February 8, 2019.
F2: The reportable securities are owned by the Alison N Hoffman and Kevin L Rakin Irrevocable Trust For Sarah Hoffman Rakin. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose, except to the extent of his pecuniary interest therein.
F3: The reportable securities are owned by the Alison N Hoffman and Kevin L Rakin Irrevocable Trust For Julia Hoffman Rakin. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose, except to the extent of his pecuniary interest therein.
F4: The reportable securities are owned by the Kevin L Rakin Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 of the Exchange Act or for any other purpose, except to the extent of his pecuniary interest therein.
Quantum-Si Inc
Report date May 18, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.85 · Expires 2036-05-18 | Direct | 251,185 |
Reported balance
After 2026-05-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-18 · Grant · Acquired 251,185 · Balance 251,185 F3: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,200,000 |
Reported balance
Holding disclosure · report date 2026-05-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,200,000 F1: HighCape Partners QSI II Invest, L.P. distributed in kind these shares of the Company's Class A common stock to its limited partners on a pro rata basis, for no consideration. F2: Consists of (i) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and (ii) 1,175,473 shares of the Company's Class A common stock held by HighCape Partners QP II, L.P. Mr. Rakin is the managing member of HighCape Capital II GP, LLC, which is the general partner of HighCape Partners II GP, L.P., which is the general partner of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P., and as a result each may be deemed to share voting and investment discretion with respect to the Class A common stock held by such entities. |
| Class A Common StockSEC Table I · non-derivative | Direct | 20,512 |
Reported balance
Holding disclosure · report date 2026-05-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 20,512 |
Filing footnotes · ownership attribution and instrument terms
F1: HighCape Partners QSI II Invest, L.P. distributed in kind these shares of the Company's Class A common stock to its limited partners on a pro rata basis, for no consideration.
F2: Consists of (i) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and (ii) 1,175,473 shares of the Company's Class A common stock held by HighCape Partners QP II, L.P. Mr. Rakin is the managing member of HighCape Capital II GP, LLC, which is the general partner of HighCape Partners II GP, L.P., which is the general partner of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P., and as a result each may be deemed to share voting and investment discretion with respect to the Class A common stock held by such entities.
F3: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 15, 2026 21:00 UTC | ELUTIA INC. ELUT · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 159,590 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0001184421-26-000004 · form4-06152026_050607.xml · derivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,590 Underlying: Class A Common Stock · 159,590 shares Expires 2036-06-11 F1 · derivative.exercise_date: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:12 UTC | ELUTIA INC. ELUT · Entity 7342 | OtherClass A Common Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-069476 · tm2616694-1_4seq1.xml · nonDerivative · entry 2 RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By trusts Disclosed balance after: 272,419 F1 · kind: Mr. Rakin caused a trust to distribute the reported securities to beneficiaries of the trust (for the avoidance of doubt, without payment of consideration by such beneficiaries). Mr. Rakin disclaims beneficial ownership of the securities held by the trusts except to the extent of his pecuniary interest therein. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:12 UTC | ELUTIA INC. ELUT · Entity 7342 | GiftClass A Common Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-069476 · tm2616694-1_4seq1.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,120 Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:05 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantStock Option (right to buy) · Derivative | 251,185 | $0.00 Strike: $0.85 | $0.00 |
DisclosureSEC source: 0001140361-26-022238 · form4.xml · derivative · entry 3 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,185 Underlying: Class A Common Stock · 251,185 shares Expires 2036-05-18 F3 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 22:01 UTC | ELUTIA INC. ELUT · Entity 7342 | PurchaseClass A Common Stock | 70,000 | $1.06 | $74,200.00 |
DisclosureSEC source: 0001104659-26-009295 · form4-02022026_100233.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,120 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.08. The reporting person undertakes to provide Elutia Inc. ( the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 21:59 UTC | ELUTIA INC. ELUT · Entity 7342 | PurchaseClass A Common Stock | 50,000 | $0.52 | $25,995.00 |
DisclosureSEC source: 0001104659-25-123259 · tm2533950-1_4seq1.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By trusts Disclosed balance after: 322,419 F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.51980 to $0.51999, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| December 11, 2025 Filed Dec 16, 2025 02:45 UTC | ELUTIA INC. ELUT · Entity 7342 | OtherClass A Common Stock | 4,372,497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-121336 · tm2533551-1_4seq1.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,978,978 F1 · kind: On December 11, 2025, HighCape Partners, L.P, HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC distributed all of their shares of the Issuer's Class A Common Stock to their partners and members pro rata according to such partners' and members' interests without payment of consideration by such partners and members. Mr. Rakin, chairman of the Issuer's board of directors, received 126,120 shares pursuant to such distribution and his irrevocable trusts received 181,612 shares. The distribution of such shares resulted in a change in the form of Mr. Rakin's beneficial ownership only. F1 · price: On December 11, 2025, HighCape Partners, L.P, HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC distributed all of their shares of the Issuer's Class A Common Stock to their partners and members pro rata according to such partners' and members' interests without payment of consideration by such partners and members. Mr. Rakin, chairman of the Issuer's board of directors, received 126,120 shares pursuant to such distribution and his irrevocable trusts received 181,612 shares. The distribution of such shares resulted in a change in the form of Mr. Rakin's beneficial ownership only. F2 · balance_after: Includes: (i) 4,562,431 shares of Common Stock held of record by HighCape Partners QP II, L.P.; (ii) 144,128 shares owned by other HighCape entities over whom Mr. Rakin may be deemed to exercise beneficial ownership in his capacity as managing member of the general partner of such entity or as managing member of the general partner of the general partner of such entity; and (iii) 272,419 shares owned by Mr. Rakin's irrevocable trusts. F3 · ownership.nature: Mr. Rakin is a managing member of HighCape Partners GP, LLC, which is the general partner ("GP") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin is the managing member of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of HighCape Partners QP II, L.P. and another HighCape entity that owns shares of record. HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. In addition, Mr. Rakin is a managing member of the GP of another HighCape entity that owns shares of record. F4 · ownership.nature: Mr. Rakin, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may have been deemed to beneficially own the securities distributed by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. Mr. Rakin, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners QP II, L.P. and the other entity for which HighCape Partners GP II, L.P. serves as GP. Finally, Mr. Rakin may be deemed to beneficially own the securities held by another HighCape entity by virtue of his serving as managing member of such entity's GP. Mr. Rakin disclaims beneficial ownership of the securities held by the other persons referred to herein except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 11, 2025 Filed Dec 17, 2025 23:08 UTC Amendment | ELUTIA INC. ELUT · Entity 7342 | OtherClass A Common Stock | 4,505,941 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-122130 · tm2533720-1_4aseq1.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,978,978 F1 · kind: On December 11, 2025, HighCape Partners, L.P, HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC distributed all of their shares of the Issuer's Class A Common Stock to their partners and members pro rata according to such partners' and members' interests without payment of consideration by such partners and members. Mr. Rakin, chairman of the Issuer's board of directors, received 126,120 shares pursuant to such distribution and his irrevocable trusts received 181,612 shares. The distribution of such shares resulted in a change in the form of Mr. Rakin's beneficial ownership only and consequently such shares are not included in the amount distributed in column 4. F5 · shares: This amended Form 4 corrects the reporting person's Form 4 filed December 15, 2025 which inadvertently misstated the number of shares of the Issuer's Class A Common Stock distributed by HighCape Partners, L.P, HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. F1 · price: On December 11, 2025, HighCape Partners, L.P, HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC distributed all of their shares of the Issuer's Class A Common Stock to their partners and members pro rata according to such partners' and members' interests without payment of consideration by such partners and members. Mr. Rakin, chairman of the Issuer's board of directors, received 126,120 shares pursuant to such distribution and his irrevocable trusts received 181,612 shares. The distribution of such shares resulted in a change in the form of Mr. Rakin's beneficial ownership only and consequently such shares are not included in the amount distributed in column 4. F2 · balance_after: Includes: (i) 4,562,431 shares of Common Stock held of record by HighCape Partners QP II, L.P.; (ii) 144,128 shares owned by other HighCape entities over whom Mr. Rakin may be deemed to exercise beneficial ownership in his capacity as managing member of the general partner of such entity or as managing member of the general partner of the general partner of such entity; and (iii) 272,419 shares owned by Mr. Rakin's irrevocable trusts. F3 · ownership.nature: Mr. Rakin is a managing member of HighCape Partners GP, LLC, which is the general partner ("GP") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin is the managing member of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of HighCape Partners QP II, L.P. and another HighCape entity that owns shares of record. HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. In addition, Mr. Rakin is a managing member of the GP of another HighCape entity that owns shares of record. F4 · ownership.nature: Mr. Rakin, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may have been deemed to beneficially own the securities distributed by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. Mr. Rakin, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners QP II, L.P. and the other entity for which HighCape Partners GP II, L.P. serves as GP. Finally, Mr. Rakin may be deemed to beneficially own the securities held by another HighCape entity by virtue of his serving as managing member of such entity's GP. Mr. Rakin disclaims beneficial ownership of the securities held by the other persons referred to herein except to the extent of his pecuniary interest therein, if any. Read SEC document |
| December 11, 2025 Filed Dec 19, 2025 21:21 UTC Amendment | ELUTIA INC. ELUT · Entity 7342 | OtherClass A Common Stock | 4,505,941 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-123182 · tm2533950-2_4aseq1.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 4,978,978 F1 · kind: On December 11, 2025, HighCape Partners, L.P, HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC distributed all of their shares of the Issuer's Class A Common Stock to their partners and members pro rata according to such partners' and members' interests without payment of consideration by such partners and members. Mr. Rakin, chairman of the Issuer's board of directors, received 126,120 shares pursuant to such distribution and his irrevocable trusts received 181,612 shares. The distribution of such shares resulted in a change in the form of Mr. Rakin's beneficial ownership only and consequently such shares are not included in the amount distributed in column 4. F5 · shares: This amendment is filed solely to add HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P., HighCape Partners QP II, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC as filers to the Form 4 originally filed by Mr. Rakin on December 15, 2025 and amended on December 17, 2025. This filing is otherwise identical in substantive content to the amended Form 4 filed by Mr. Rakin on December 17, 2025. F1 · price: On December 11, 2025, HighCape Partners, L.P, HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC distributed all of their shares of the Issuer's Class A Common Stock to their partners and members pro rata according to such partners' and members' interests without payment of consideration by such partners and members. Mr. Rakin, chairman of the Issuer's board of directors, received 126,120 shares pursuant to such distribution and his irrevocable trusts received 181,612 shares. The distribution of such shares resulted in a change in the form of Mr. Rakin's beneficial ownership only and consequently such shares are not included in the amount distributed in column 4. F2 · balance_after: Includes: (i) 4,562,431 shares of Common Stock held of record by HighCape Partners QP II, L.P.; (ii) 144,128 shares owned by other HighCape entities over whom Mr. Rakin may be deemed to exercise beneficial ownership in his capacity as managing member of the general partner of such entity or as managing member of the general partner of the general partner of such entity; and (iii) 272,419 shares owned by Mr. Rakin's irrevocable trusts. F3 · ownership.nature: Mr. Rakin is a managing member of HighCape Partners GP, LLC, which is the general partner ("GP") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin is the managing member of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of HighCape Partners QP II, L.P. and another HighCape entity that owns shares of record. HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. In addition, Mr. Rakin is a managing member of the GP of another HighCape entity that owns shares of record. F4 · ownership.nature: Mr. Rakin, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may have been deemed to beneficially own the securities distributed by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. Mr. Rakin, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners QP II, L.P. and the other entity for which HighCape Partners GP II, L.P. serves as GP. Finally, Mr. Rakin may be deemed to beneficially own the securities held by another HighCape entity by virtue of his serving as managing member of such entity's GP. Mr. Rakin disclaims beneficial ownership of the securities held by the other persons referred to herein except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 21:00 UTC | ELUTIA INC. ELUT · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 90,509 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001415889-25-015203 · form4-06022025_050609.xml · derivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,509 Underlying: Class A Common Stock · 90,509 shares Expires 2035-05-29 F1 · derivative.exercise_date: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:01 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantStock Option (right to buy) · Derivative | 126,095 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001140361-25-020042 · form4.xml · derivative · entry 3 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,095 Underlying: Class A Common Stock · 126,095 shares Expires 2035-05-19 F3 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date. Read SEC document |
| February 03, 2025 Filed Mar 13, 2025 20:28 UTC | ELUTIA INC. ELUT · Entity 7342 | PurchaseClass A Common Stock | 420,000 | $2.50 | $1,050,000.00 |
DisclosureSEC source: 0001104659-25-023484 · tm259106-1_4seq1.xml · nonDerivative · entry 1 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,520,232 F1 · ownership.nature: Includes: (i) 53,818 shares of Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Common Stock held of record by HighCape Capital, L.P; (vi) 95,197 shares of Common Stock held of record by HighCape Partners II, L.P.; and (vii) 4,562,431 shares of Common Stock held of record by HighCape Partners QP II, L.P. F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner ("GP") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the GP of HighCape Capital, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P. In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. F3 · ownership.nature: Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC, and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. In addition, each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners II, L.P. and HighCape Partners QP II, L.P. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 20:54 UTC | ELUTIA INC. ELUT · Entity 7342 | OtherWarrants (right to buy) · Derivative | 2,101,577 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001104659-24-084967 · tm2420609-2_4seq1.xml · derivative · entry 2 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 2,101,577 shares Expires not disclosed F4 · derivative.expiration_date: The warrant has expired. The warrant provided for expiration upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope (which has elapsed) or (b) September 21, 2028. F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner ("GP") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the GP of HighCape Capital, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P. In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. F3 · ownership.nature: Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC, and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. In addition, each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners II, L.P. and HighCape Partners QP II, L.P. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. F5 · ownership.nature: Warrants for 2,058,623 shares of Common Stock were exercised by HighCape Partners QP II, L.P. and warrants for 42,954 shares of Common Stock were exercised by HighCape Partners II, L.P. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 20:54 UTC | ELUTIA INC. ELUT · Entity 7342 | OtherClass A Common Stock | 2,101,577 | $1.43 | $3,000,001.17 |
DisclosureSEC source: 0001104659-24-084967 · tm2420609-2_4seq1.xml · nonDerivative · entry 1 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 9,100,232 F1 · ownership.nature: Includes: (i) 53,818 shares of Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Common Stock held of record by HighCape Capital, L.P; (vi) 86,613 shares of Common Stock held of record by HighCape Partners II, L.P.; and (vii) 4,151,015 shares of Common Stock held of record by HighCape Partners QP II, L.P. F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner ("GP") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the GP of HighCape Capital, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P. In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. F3 · ownership.nature: Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC, and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. In addition, each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners II, L.P. and HighCape Partners QP II, L.P. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 21:00 UTC | ELUTIA INC. ELUT · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 47,753 | $0.00 Strike: $3.40 | $0.00 |
DisclosureSEC source: 0001415889-24-016250 · form4-06102024_050614.xml · derivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,753 Underlying: Class A Common Stock · 47,753 shares Expires 2034-06-05 F1 · derivative.exercise_date: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:47 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantStock Option (right to buy) · Derivative | 113,281 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001140361-24-026709 · form4.xml · derivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,281 Underlying: Class A Common Stock · 113,281 shares Expires 2034-05-16 F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Rakin's continued service through the applicable vesting date. Read SEC document |
| December 28, 2023 Filed Jan 8, 2024 21:09 UTC | ELUTIA INC. ELUT · Entity 7342 | OtherWarrants (right to buy) · Derivative | 2,154,116 | Not disclosed Strike: $1.43 | Not disclosed |
DisclosureSEC source: 0001104659-24-002239 · tm242311-2_4seq1.xml · derivative · entry 2 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 2,101,577 Underlying: Class A Common Stock · 2,154,116 shares Expires not disclosed F7 · kind: This Form 4 relates to the pro rata distribution by Elutia PIPE Investment LP of its shares of Class A Common Stock and Warrants to its partners, without payment of consideration by such partners. F1 · price: The reported securities are included within 1,436,077 Units originally purchased by Elutia PIPE Investment LP for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock (the "Common Stock") and one warrant to purchase one and one-half shares of Common Stock. The shares of Common Stock and Warrants reported as transferred in this Form 4 are being distributed to Elutia PIPE Investment LP's partners without payment of consideration by them. F5 · derivative.expiration_date: The warrant expires upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope or (b) September 21, 2028. F6 · ownership.nature: Includes (i) 2,058,623 shares of Common Stock issuable upon exercise of a warrant held by HighCape Partners QP II, L.P.; and (ii) 42,954 shares of Common Stock issuable upon exercise of a warrant held by HighCape Partners II, L.P. Read SEC document |
| December 28, 2023 Filed Jan 8, 2024 21:09 UTC | ELUTIA INC. ELUT · Entity 7342 | OtherClass A Common Stock | 1,436,077 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-002239 · tm242311-2_4seq1.xml · nonDerivative · entry 1 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 6,998,655 F7 · kind: This Form 4 relates to the pro rata distribution by Elutia PIPE Investment LP of its shares of Class A Common Stock and Warrants to its partners, without payment of consideration by such partners. F1 · price: The reported securities are included within 1,436,077 Units originally purchased by Elutia PIPE Investment LP for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock (the "Common Stock") and one warrant to purchase one and one-half shares of Common Stock. The shares of Common Stock and Warrants reported as transferred in this Form 4 are being distributed to Elutia PIPE Investment LP's partners without payment of consideration by them. F2 · ownership.nature: Includes: (i) 53,818 shares of Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Common Stock held of record by HighCape Capital, L.P; (vi) 43,659 shares of Common Stock held of record by HighCape Partners II, L.P.; and (vii) 2,092,392 shares of Common Stock held of record by HighCape Partners QP II, L.P. F3 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner ("GP") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the GP of HighCape Capital, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of each of HighCape Partners II, L.P., HighCape Partners QP II, L.P. and Elutia PIPE Investment, LP. In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. F4 · ownership.nature: Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC, and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. In addition, each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners II, L.P., HighCape Partners QP II, L.P. and Elutia PIPE Investment, LP. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 19:32 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001104659-23-070300 · tm2318353-1_4seq1.xml · derivative · entry 2 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · Director · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · Director · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · Director · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · Director · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · Director · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · Director · 10% owner HighCape Capital, LLC · CIK 0001827500 · Director · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2033-06-07 F1 · derivative.exercise_date: This option was granted automatically under the Issuer's First Amended and Restated Non-Employee Director Compensation Policy and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date. F3 · ownership.nature: Held by W. Matthew Zuga as non-employee member of the Issuer's board of directors. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 19:32 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $2.37 | $0.00 |
DisclosureSEC source: 0001104659-23-070300 · tm2318353-1_4seq1.xml · derivative · entry 1 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · Director · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · Director · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · Director · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · Director · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · Director · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · Director · 10% owner HighCape Capital, LLC · CIK 0001827500 · Director · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 37,500 Underlying: Class A Common Stock · 37,500 shares Expires 2033-06-07 F1 · derivative.exercise_date: This option was granted automatically under the Issuer's First Amended and Restated Non-Employee Director Compensation Policy and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date. F2 · ownership.nature: Held by Kevin L. Rakin as non-employee member of the Issuer's board of directors. Read SEC document |
| May 12, 2023 Filed May 16, 2023 21:09 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantStock Option (right to buy) · Derivative | 120,481 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001140361-23-025068 · form4.xml · derivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,481 Underlying: Class A Common Stock · 120,481 shares Expires 2033-05-12 F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Rakin's continued service through the applicable vesting date. Read SEC document |
| December 22, 2022 Filed Dec 27, 2022 23:09 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 17,533 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001415889-22-013020 · form4-12272022_111257.xml · derivative · entry 1 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · Director · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 17,533 Underlying: Class A Common Stock · 17,533 shares Expires 2032-12-21 F1 · derivative.exercise_date: This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date. F2 · ownership.nature: Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 21:16 UTC | Quantum-Si Inc QSI · Entity 6440 | OtherClass A Common Stock | 601,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-046663 · form4.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,200,000 F1 · kind: HighCape Partners QSI II Invest, L.P. distributed in kind these shares of the Company's Class A common stock to its limited partners on a pro rata basis, for no consideration. F2 · balance_after: Consists of (i) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and (ii) 1,175,473 shares of the Company's Class A common stock held by HighCape Partners QP II, L.P. Mr. Rakin and Matt Zuga are the managing members of HighCape Capital II GP, LLC, which is the general partner of HighCape Partners II GP, L.P., which is the general partner of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P., and as a result each may be deemed to share voting and investment discretion with respect to the Class A common stock held by such entities. F3 · balance_after: Mr. Rakin disclaims any beneficial ownership of the securities to be held by HighCape Partners II, L.P. and HighCape Partners QP II, L.P. other than to the extent of any pecuniary interest he may have therein, directly or indirectly. F2 · ownership.nature: Consists of (i) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and (ii) 1,175,473 shares of the Company's Class A common stock held by HighCape Partners QP II, L.P. Mr. Rakin and Matt Zuga are the managing members of HighCape Capital II GP, LLC, which is the general partner of HighCape Partners II GP, L.P., which is the general partner of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P., and as a result each may be deemed to share voting and investment discretion with respect to the Class A common stock held by such entities. F3 · ownership.nature: Mr. Rakin disclaims any beneficial ownership of the securities to be held by HighCape Partners II, L.P. and HighCape Partners QP II, L.P. other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:08 UTC | Quantum-Si Inc QSI · Entity 6440 | SaleClass A Common Stock | 89,000 | $2.15 | $191,234.30 |
DisclosureSEC source: 0001140361-22-045863 · form4.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,801,000 F1 · shares: Includes 39,000 shares sold by Mr. Rakin and 50,000 shares sold by the Kevin L. Rakin Irrevocable Trust. F2 · balance_after: Consists of (i) 601,000 shares of the Company's Class A common stock held by HighCape Partners QSI II Invest, L.P, (ii) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and (iii) 1,175,473 shares of the Company's Class A common stock held by HighCape Partners QP II, L.P. Mr. Rakin and Matt Zuga are the managing members of HighCape Capital II GP, LLC, which is the general partner of HighCape Partners II GP, L.P., which is the general partner of each of HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P., and as a result each may be deemed to share voting and investment discretion with respect to the common stock held by such entities. F3 · balance_after: Mr. Rakin disclaims any beneficial ownership of the securities to be held by HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P. other than to the extent of any pecuniary interest he may have therein, directly or indirectly. F2 · ownership.nature: Consists of (i) 601,000 shares of the Company's Class A common stock held by HighCape Partners QSI II Invest, L.P, (ii) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and (iii) 1,175,473 shares of the Company's Class A common stock held by HighCape Partners QP II, L.P. Mr. Rakin and Matt Zuga are the managing members of HighCape Capital II GP, LLC, which is the general partner of HighCape Partners II GP, L.P., which is the general partner of each of HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P., and as a result each may be deemed to share voting and investment discretion with respect to the common stock held by such entities. F3 · ownership.nature: Mr. Rakin disclaims any beneficial ownership of the securities to be held by HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P. other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Read SEC document |
| December 05, 2022 Filed Dec 7, 2022 21:31 UTC | ELUTIA INC. AZYO · Entity 7342 | PurchaseClass A Common Stock | 735,000 | $4.75 | $3,491,250.00 |
DisclosureSEC source: 0001104659-22-125197 · tm2232148-1_4seq1.xml · nonDerivative · entry 1 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 5,597,604 F1 · ownership.nature: Includes: (i) 53,818 shares of Class A Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Class A Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Class A Common Stock held of record by HighCape Capital, L.P.; (vi) 15,023 shares of Class A Common Stock held of record by HighCape Partners II, L.P.; and (vii) 719,977 shares of Class A Common Stock held of record by HighCape Partners QP II, L.P. F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner of HighCape Partners GP, L.P., which is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Messrs. Rakin and Zuga are the managing members of HighCape Capital, LLC, which is the general partner of HighCape Capital, L.P. Messrs. Rakin and Zuga are also the managing members of HighCape Partners GP II, LLC, which is the general partner of HighCape Partners GP II, L.P., which is the general partner of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P. F3 · ownership.nature: Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held of record by each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held of record by HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held of record by each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P. F4 · ownership.nature: In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held of record by each such entity. Mr. Rakin may be deemed to beneficially own the securities held of record by the Kevin L. Rakin Irrevocable Trust. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 12:28 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 22,090 | $0.00 Strike: $6.28 | $0.00 |
DisclosureSEC source: 0001415889-22-006330 · form4-06092022_050626.xml · derivative · entry 2 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · Director · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 22,090 Underlying: Class A Common Stock · 22,090 shares Expires 2032-06-06 F1 · derivative.exercise_date: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date. F3 · ownership.nature: Held by W. Matthew Zuga as non-employee member of the Issuer's board of directors. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 12:28 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 22,090 | $0.00 Strike: $6.28 | $0.00 |
DisclosureSEC source: 0001415889-22-006330 · form4-06092022_050626.xml · derivative · entry 1 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · Director · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 22,090 Underlying: Class A Common Stock · 22,090 shares Expires 2032-06-06 F1 · derivative.exercise_date: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date. F2 · ownership.nature: Held by Kevin L. Rakin as non-employee member of the Issuer's board of directors. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:19 UTC | Quantum-Si Inc QSI · Entity 6440 | GrantStock Option (right to buy) · Derivative | 59,880 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001140361-22-019090 · form4.xml · derivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,880 Underlying: Class A Common Stock · 59,880 shares Expires 2032-05-11 F1 · derivative.exercise_date: The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Rakin's continued service through the applicable vesting date Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 00:30 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | SaleCommon Stock | 10,000 | $9.41 | $94,096.00 |
DisclosureSEC source: 0001213900-22-014283 · ownership.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,661 Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:30 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | Exercise / conversionStock Option (right to buy) · Derivative | 6,667 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001213900-22-008755 · ownership.xml · derivative · entry 3 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,667 shares Expires 2030-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:30 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | Tax withholdingCommon Stock | 3,010 | $10.63 | $31,996.30 |
DisclosureSEC source: 0001213900-22-008755 · ownership.xml · nonDerivative · entry 2 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,661 F1 · shares: Represents a cashless exercise of outstanding stock options to purchase 6,667 shares of common stock. The reporting person received 3,657 shares of common stock and surrendered 3,010 shares of common stock underlying the stock option in payment of the exercise price. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:30 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | Exercise / conversionCommon Stock | 6,667 | $4.80 | $32,001.60 |
DisclosureSEC source: 0001213900-22-008755 · ownership.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2022 Filed Feb 14, 2022 22:30 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-007695 · ownership.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,004 F1 · price: This transaction represents a charitable donation effective February 11, 2022. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 22:30 UTC Amendment | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-007951 · ownership.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,004 F1 · price: This transaction represents a charitable donation effective February 11, 2022. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. F2 · balance_after: This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Rakin, which reported that 47,004 shares of common stock are beneficially owned by him following the reported transaction. Mr. Rakin beneficially owned 53,004 shares of common stock following the reported transaction. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:35 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $13.89 | $0.00 |
DisclosureSEC source: 0001213900-22-000810 · ownership.xml · derivative · entry 2 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2032-01-03 F2 · derivative.exercise_date: The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 01:35 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | GrantCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-000810 · ownership.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,004 F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 22:15 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-066053 · ownership.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,004 F1 · price: This transaction represents a charitable donation effective December 16, 2021. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:22 UTC | ELUTIA INC. AZYO · Entity 7342 | PurchaseClass A Common Stock | 58,962 | $4.24 | $249,998.88 |
DisclosureSEC source: 0001104659-21-148591 · tm2135128-1_4seq1.xml · nonDerivative · entry 2 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Kevin L. Rakin Irrevocable Trust Disclosed balance after: 90,807 Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 21:22 UTC | ELUTIA INC. AZYO · Entity 7342 | PurchaseClass A Common Stock | 353,773 | $4.24 | $1,499,997.52 |
DisclosureSEC source: 0001104659-21-148591 · tm2135128-1_4seq1.xml · nonDerivative · entry 1 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner HighCape Capital, LLC · CIK 0001827500 · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 4,862,604 F1 · ownership.nature: Includes: (i) 53,818 shares of Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; and (v) 48,931 shares of Common Stock held of record by HighCape Capital, L.P. F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner of HighCape Partners GP, L.P., which is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the general partner of HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P. and HighCape Partners QP, L.P., and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. F3 · ownership.nature: In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held by such entities. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. Read SEC document |
| November 03, 2021 Filed Feb 10, 2022 21:34 UTC | Quantum-Si Inc QSI · Entity 6440 | GiftClass A Common Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-004540 · form5.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,890,000 F1 · shares: These shares of Class A common stock were transferred by Mr. Rakin as bona fide gifts for which no payment of consideration was received by Mr. Rakin. F2 · balance_after: Consists of (i) 89,000 shares of the Company's Class A common stock held by Mr. Rakin and the Kevin L. Rakin Irrevocable Trust, (ii) 601,000 shares of the Company's Class A common stock held by HighCape Partners QSI II Invest, L.P, (iii) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and (iv) 1,175,473 shares of the Company's Class A common stock held by HighCape Partners QP II, L.P. Mr. Rakin and Matt Zuga are the managing members of HighCape Capital II GP, LLC, which is the general partner of HighCape Partners II GP, L.P., which is the general partner of each of HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P., and as a result each may be deemed to share voting and investment discretion with respect to the common stock held by such entities. F3 · balance_after: Mr. Rakin disclaims any beneficial ownership of the securities to be held by HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P. other than to the extent of any pecuniary interest he may have therein, directly or indirectly. F2 · ownership.nature: Consists of (i) 89,000 shares of the Company's Class A common stock held by Mr. Rakin and the Kevin L. Rakin Irrevocable Trust, (ii) 601,000 shares of the Company's Class A common stock held by HighCape Partners QSI II Invest, L.P, (iii) 24,527 shares of the Company's Class A common stock held by HighCape Partners II, L.P. and (iv) 1,175,473 shares of the Company's Class A common stock held by HighCape Partners QP II, L.P. Mr. Rakin and Matt Zuga are the managing members of HighCape Capital II GP, LLC, which is the general partner of HighCape Partners II GP, L.P., which is the general partner of each of HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P., and as a result each may be deemed to share voting and investment discretion with respect to the common stock held by such entities. F3 · ownership.nature: Mr. Rakin disclaims any beneficial ownership of the securities to be held by HighCape Partners QSI II Invest, L.P, HighCape Partners II, L.P. and HighCape Partners QP II, L.P. other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Read SEC document |
| September 21, 2021 Filed Oct 5, 2023 20:43 UTC | ELUTIA INC. ELUT · Entity 7342 | PurchaseWarrants (right to buy) · Derivative | 4,255,693 | Not disclosed Strike: $1.43 | Not disclosed |
DisclosureSEC source: 0001826279-23-000002 · primary_doc.xml · derivative · entry 2 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 4,255,693 Underlying: Class A Common Stock · 4,255,693 shares Expires not disclosed F1 · price: The reported securities are included within the 2,837,128 Units purchased by the reporting persons for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock (the "Common Stock") and one warrant to purchase one and one-half shares of Common Stock. F5 · derivative.expiration_date: The warrant expires upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope or (b) September 21, 2028. F6 · ownership.nature: Includes (i) 2,058,623 shares of Common Stock issuable upon exercise of a warrant held by HighCape Partners QP II, L.P.; (ii) 42,954 shares of Common Stock issuable upon exercise of a warrant held by HighCape Partners II, L.P; and (iii) 2,154,116 shares of Common Stock issuable upon exercise of a warrant held by Elutia PIPE Investment, LP. Read SEC document |
| September 21, 2021 Filed Oct 5, 2023 20:43 UTC | ELUTIA INC. ELUT · Entity 7342 | PurchaseClass A Common Stock | 2,837,128 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001826279-23-000002 · primary_doc.xml · nonDerivative · entry 1 HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner Zuga Matt · CIK 0001790214 · Director · 10% owner RAKIN KEVIN · CIK 0001184421 · Director · 10% owner HighCape Partners GP, LLC · CIK 0001819933 · 10% owner HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 8,434,732 F1 · price: The reported securities are included within the 2,837,128 Units purchased by the reporting persons for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock (the "Common Stock") and one warrant to purchase one and one-half shares of Common Stock. F2 · ownership.nature: Includes: (i) 53,818 shares of Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Common Stock held of record by HighCape Capital, L.P; (vi) 43,659 shares of Common Stock held of record by HighCape Partners II, L.P.; (vii) 2,092,392 shares of Common Stock held of record by HighCape Partners QP II, L.P.; and (viii) 1,436,077 shares of Common Stock held of record by Elutia PIPE Investment, LP. F3 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner ("GP") of HighCape Partners GP, L.P., which is the GP of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Capital, LLC, which is the GP of HighCape Capital, L.P. Mr. Rakin and Mr. Zuga are the managing members of HighCape Partners GP II, LLC, which is the GP of HighCape Partners GP II, L.P., which is the GP of each of HighCape Partners II, L.P., HighCape Partners QP II, L.P. and Elutia PIPE Investment, LP. In addition, HighCape Partners GP, L.P. manages each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC. F4 · ownership.nature: Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held by HighCape Partners, L.P., HighCape Partners QP, L.P., HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC, and each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held by HighCape Capital, L.P. In addition, each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held by HighCape Partners II, L.P., HighCape Partners QP II, L.P. and Elutia PIPE Investment, LP. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any. Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 20:01 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | SaleCommon Stock | 21,100 | $20.99 | $442,829.92 |
DisclosureSEC source: 0001213900-21-048832 · ownership.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,004 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 20:44 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | GrantCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-046408 · ownership.xml · nonDerivative · entry 1 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,104 F1 · price: Restricted Stock Units ("RSUs") granted in February 2021 and vested upon achievement of certain vesting conditions. The RSUs convert into Issuer's common stock on a one-for-one basis. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 21:15 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | Exercise / conversionStock Option (right to buy) · Derivative | 56,773 | $0.00 Strike: $7.77 | $0.00 |
DisclosureSEC source: 0001213900-21-041712 · ownership.xml · derivative · entry 12 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,773 shares Expires 2027-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The options vested as follows: 15,591 vested on December 31, 2017, 2018 and 2019 and additional 10,000 vested on December 31, 2020. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 21:15 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.17 | $0.00 |
DisclosureSEC source: 0001213900-21-041712 · ownership.xml · derivative · entry 11 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2029-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 21:15 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | Exercise / conversionStock Option (right to buy) · Derivative | 6,666 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001213900-21-041712 · ownership.xml · derivative · entry 10 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,666 shares Expires 2030-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 21:15 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | Exercise / conversionStock Option (right to buy) · Derivative | 5,697 | $0.00 Strike: $6.23 | $0.00 |
DisclosureSEC source: 0001213900-21-041712 · ownership.xml · derivative · entry 9 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,697 shares Expires 2027-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 21:15 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | Tax withholdingCommon Stock | 20,916 | $21.09 | $441,118.44 |
DisclosureSEC source: 0001213900-21-041712 · ownership.xml · nonDerivative · entry 8 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,104 F4 · shares: Represents a cashless exercise of outstanding stock options to purchase 56,773 shares of common stock. The reporting person received 35,857 shares of common stock and surrendered 20,916 shares of common stock underlying the stock option in payment of the exercise price. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 21:15 UTC | ORAMED PHARMACEUTICALS INC. ORMP · Entity 6311 | Exercise / conversionCommon Stock | 56,773 | $7.77 | $441,126.21 |
DisclosureSEC source: 0001213900-21-041712 · ownership.xml · nonDerivative · entry 7 RAKIN KEVIN · CIK 0001184421 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.